Clinical Trials on Genital Neoplasms, Female

Conditions: Cervical Cancer

Conditions: Organoids; Epithelial Ovarian Cancer

Conditions: Small Cell Lung Cancer; Ovarian Cancer; Triple Negative Breast Cancer; Non-small Cell Lung Cancer; Human Receptor-positive Human Epidermal Growth Factor Receptor 2

Conditions: Advanced Breast Carcinoma; Advanced Malignant Solid Neoplasm; Advanced Ovarian Carcinoma; Advanced Pancreatic Carcinoma; Advanced Prostate Carcinoma; Anatomic Stage III Breast Cancer AJCC v8; Anatomic Stage IIIA Breast Cancer AJCC v8; Anatomic Stage IIIB Breast Cancer AJCC v8; Anatomic Stage IIIC Breast Cancer AJCC v8; Anatomic Stage IV Breast Cancer AJCC v8; Castration-Resistant Prostate Carcinoma; Clinical Stage III Gastric Cancer AJCC v8; Clinical Stage IV Gastric Cancer AJCC v8; Clinical Stage IVA Gastric Cancer AJCC v8; Clinical Stage IVB Gastric Cancer AJCC v8; HER2 Positive Breast Carcinoma; Metastatic Prostate Carcinoma; Pathologic Stage III Gastric Cancer AJCC v8; Pathologic Stage IIIA Gastric Cancer AJCC v8; Pathologic Stage IIIB Gastric Cancer AJCC v8; Pathologic Stage IIIC Gastric Cancer AJCC v8; Pathologic Stage IV Gastric Cancer AJCC v8; Platinum-Sensitive Ovarian Carcinoma; Postneoadjuvant Therapy Stage III Gastric Cancer AJCC v8; Postneoadjuvant Therapy Stage IV Gastric Cancer AJCC v8; Prognostic Stage III Breast Cancer AJCC v8; Prognostic Stage IIIA Breast Cancer AJCC v8; Prognostic Stage IIIB Breast Cancer AJCC v8; Prognostic Stage IIIC Breast Cancer AJCC v8; Prognostic Stage IV Breast Cancer AJCC v8; Stage II Pancreatic Cancer AJCC v8; Stage IIA Pancreatic Cancer AJCC v8; Stage IIB Pancreatic Cancer AJCC v8; Stage III Pancreatic Cancer AJCC v8; Stage III Prostate Cancer AJCC v8; Stage IIIA Ovarian Cancer AJCC v8; Stage IIIA Prostate Cancer AJCC v8; Stage IIIA1 Ovarian Cancer AJCC v8; Stage IIIA2 Ovarian Cancer AJCC v8; Stage IIIB Ovarian Cancer AJCC v8; Stage IIIB Prostate Cancer AJCC v8; Stage IIIC Ovarian Cancer AJCC v8; Stage IIIC Prostate Cancer AJCC v8; Stage IV Ovarian Cancer AJCC v8; Stage IV Pancreatic Cancer AJCC v8; Stage IV Prostate Cancer AJCC v8; Stage IVA Ovarian Cancer AJCC v8; Stage IVA Prostate Cancer AJCC v8; Stage IVB Ovarian Cancer AJCC v8; Stage IVB Prostate Cancer AJCC v8

Conditions: Cervical Cancer; Diagnostic Platform; Cervical Cytology Screening

Conditions: Cervical Cancer

Conditions: Epithelial Ovarian Cancer; Fallopian Tube Cancer; Primary Peritoneal Cancer

Conditions: Hereditary Breast and Ovarian Cancer Syndrome

Conditions: Vulvar Neoplasm

Conditions: Cervical Cancer

Conditions: Ovarian Cancer

Conditions: Epithelial Ovarian Cancer; Fallopian Tube Cancer; Primary Peritoneal Cancer

Conditions: Cervical Intraepithelial Neoplasia; Cervical Cancer; Condylomata Acuminata

Conditions: Cervical Cancer

Conditions: Ovarian Cancer, Epithelial; Peritoneal Cancer; Fallopian Tube Cancer

Conditions: Ovarian Cancer

Conditions: Malignant Neoplasm; Malignant Neoplasm of Rectum; Malignant Neoplasm of Anus; Malignant Neoplasm of Urinary Bladder; Malignant Neoplasm of Cervix; Malignant Neoplasm of Ovary; Malignant Neoplasm of Prostate; Malignant Neoplasm of Large Intestine; Malignant Neoplasm of Colon; Gynecologic Cancer

Conditions: Breast Cancer; Prostate Cancer; Melanoma (Skin); Endometrial Cancer; Gallbladder Cancer; Rectal Cancer; Kidney Cancer; Bladder Cancer

Conditions: Ovary Cancer

Conditions: Cervical Cancer; Cervical Intraepithelial Neoplasia; Human Papilloma Virus; HPV-Related Cervical Carcinoma; Urine

Conditions: Endometrial Cancer

Conditions: Endometrial Cancer; Ovarian Cancer

Conditions: Ovarian Cancer; Fatigue; Coping Behavior; Coping Skills

Conditions: Solid Tumor, Adult; FGFR2 Amplification; FGFR2 Gene Mutation; FGFR2 Gene Rearrangement; FGFR2 Gene Translocation; FGFR2 Gene Activation; Intrahepatic Cholangiocarcinoma; Cholangiocarcinoma; Endometrial Cancer; Gastric Cancer; Breast Cancer

Conditions: Ovary Cancer

Conditions: Ovarian Cancer

Conditions: Ovarian Cancer; Cognitive Impairment

Conditions: Human Papillomavirus (HPV)-Related Cervical Cancer; HPV DNA

Conditions: Efficacy and Safety

Conditions: Ovarian Neoplasms; Carcinoma, Ovarian Epithelial; Neoplasm of Stomach; Ovarian Diseases; Genital Neoplasms, Female; Ovarian Epithelial Tumor; Urogenital Neoplasms; Neoplasms, Glandular and Epithelial

Conditions: Metastatic Malignant Female Reproductive System Neoplasm

Conditions: Solid Tumor; Epithelial Ovarian Cancer; Fallopian Tube Cancer; Peritoneal Cancer

Conditions: Uterine Cervical Neoplasm; Uterine Cervical Cancer; Cervical Cancer

Conditions: Bronchial Carcinoma; Esophageal Carcinoma; Tumor of the Brain; Head and Neck Cancer; Pancreas Cancer; Sarcoma; Cervix Uteri Cancer

Conditions: Relapsed Ovarian Cancer

Conditions: Advanced Differentiated Thyroid Gland Carcinoma; Advanced Head and Neck Carcinoma; Advanced Hepatocellular Carcinoma; Advanced Kaposi Sarcoma; Advanced Lung Non-Small Cell Carcinoma; Advanced Lung Small Cell Carcinoma; Advanced Malignant Solid Neoplasm; Advanced Melanoma; Advanced Ovarian Carcinoma; Advanced Prostate Carcinoma; Advanced Renal Cell Carcinoma; Advanced Thyroid Gland Medullary Carcinoma; Advanced Urothelial Carcinoma; Anatomic Stage III Breast Cancer AJCC v8; Anatomic Stage IIIA Breast Cancer AJCC v8; Anatomic Stage IIIB Breast Cancer AJCC v8; Anatomic Stage IIIC Breast Cancer AJCC v8; Anatomic Stage IV Breast Cancer AJCC v8; Castration-Resistant Prostate Carcinoma; Clinical Stage III Cutaneous Melanoma AJCC v8; Clinical Stage IV Cutaneous Melanoma AJCC v8; HIV Infection; Metastatic Differentiated Thyroid Gland Carcinoma; Metastatic Head and Neck Carcinoma; Metastatic Hepatocellular Carcinoma; Metastatic Kaposi Sarcoma; Metastatic Lung Non-Small Cell Carcinoma; Metastatic Lung Small Cell Carcinoma; Metastatic Malignant Solid Neoplasm; Metastatic Melanoma; Metastatic Ovarian Carcinoma; Metastatic Prostate Carcinoma; Metastatic Renal Cell Carcinoma; Metastatic Thyroid Gland Medullary Carcinoma; Metastatic Triple-Negative Breast Carcinoma; Metastatic Urothelial Carcinoma; Pathologic Stage III Cutaneous Melanoma AJCC v8; Pathologic Stage IIIA Cutaneous Melanoma AJCC v8; Pathologic Stage IIIB Cutaneous Melanoma AJCC v8; Pathologic Stage IIIC Cutaneous Melanoma AJCC v8; Pathologic Stage IIID Cutaneous Melanoma AJCC v8; Pathologic Stage IV Cutaneous Melanoma AJCC v8; Prognostic Stage III Breast Cancer AJCC v8; Prognostic Stage IIIA Breast Cancer AJCC v8; Prognostic Stage IIIB Breast Cancer AJCC v8; Prognostic Stage IIIC Breast Cancer AJCC v8; Prognostic Stage IV Breast Cancer AJCC v8; Recurrent Differentiated Thyroid Gland Carcinoma; Recurrent Head and Neck Carcinoma; Recurrent Hepatocellular Carcinoma; Recurrent Kaposi Sarcoma; Recurrent Lung Non-Small Cell Carcinoma; Recurrent Lung Small Cell Carcinoma; Recurrent Malignant Solid Neoplasm; Recurrent Melanoma; Recurrent Ovarian Carcinoma; Recurrent Prostate Carcinoma; Recurrent Renal Cell Carcinoma; Recurrent Thyroid Gland Medullary Carcinoma; Recurrent Triple-Negative Breast Carcinoma; Recurrent Urothelial Carcinoma; Refractory Differentiated Thyroid Gland Carcinoma; Stage III Differentiated Thyroid Gland Carcinoma AJCC v8; Stage III Hepatocellular Carcinoma AJCC v8; Stage III Lung Cancer AJCC v8; Stage III Ovarian Cancer AJCC v8; Stage III Prostate Cancer AJCC v8; Stage III Renal Cell Cancer AJCC v8; Stage III Thyroid Gland Medullary Carcinoma AJCC v8; Stage IIIA Hepatocellular Carcinoma AJCC v8; Stage IIIA Lung Cancer AJCC v8; Stage IIIA Ovarian Cancer AJCC v8; Stage IIIA Prostate Cancer AJCC v8; Stage IIIA1 Ovarian Cancer AJCC v8; Stage IIIA2 Ovarian Cancer AJCC v8; Stage IIIB Hepatocellular Carcinoma AJCC v8; Stage IIIB Lung Cancer AJCC v8; Stage IIIB Ovarian Cancer AJCC v8; Stage IIIB Prostate Cancer AJCC v8; Stage IIIC Lung Cancer AJCC v8; Stage IIIC Ovarian Cancer AJCC v8; Stage IIIC Prostate Cancer AJCC v8; Stage IV Differentiated Thyroid Gland Carcinoma AJCC v8; Stage IV Hepatocellular Carcinoma AJCC v8; Stage IV Lung Cancer AJCC v8; Stage IV Ovarian Cancer AJCC v8; Stage IV Prostate Cancer AJCC v8; Stage IV Renal Cell Cancer AJCC v8; Stage IV Thyroid Gland Medullary Carcinoma AJCC v8; Stage IVA Differentiated Thyroid Gland Carcinoma AJCC v8; Stage IVA Hepatocellular Carcinoma AJCC v8; Stage IVA Lung Cancer AJCC v8; Stage IVA Ovarian Cancer AJCC v8; Stage IVA Prostate Cancer AJCC v8; Stage IVA Thyroid Gland Medullary Carcinoma AJCC v8; Stage IVB Differentiated Thyroid Gland Carcinoma AJCC v8; Stage IVB Hepatocellular Carcinoma AJCC v8; Stage IVB Lung Cancer AJCC v8; Stage IVB Ovarian Cancer AJCC v8; Stage IVB Prostate Cancer AJCC v8; Stage IVB Thyroid Gland Medullary Carcinoma AJCC v8; Stage IVC Thyroid Gland Medullary Carcinoma AJCC v8; Triple-Negative Breast Carcinoma

Conditions: Cervix Cancer; Endometrial Cancer

Conditions: Epithelial Ovarian Cancer; Fallopian Tube Cancer; Primary Peritoneal Carcinoma

Conditions: Cancer Gene Mutation; Lynch Syndrome; Endometrial Cancer; Somatic Mutation

Conditions: Endometrial Cancer; Carcinosarcoma

Conditions: Endometrial Cancer; Sentinel Lymph Node; Indocyanine Green

Conditions: Predictive Cancer Model

Conditions: Gynecologic Cancer; Endometrial Cancer; Cervical Cancer; Quality of Life; Opioid Use

Conditions: Ovarian Endometrioid Tumor; Fallopian Tube Cancer; Primary Peritoneal Cancer; TP53 Mutation

Conditions: Endometrial Cancer

Conditions: Immune Checkpoint Inhibition

Conditions: Ovarian Cancer

Conditions: Cervical Cancer

Conditions: Benign Neoplasm of Cervix Uteri; Gynecological Laparoscopy

Conditions: Hereditary Breast and Ovarian Cancer; Lynch Syndrome